Ganjaran Bonus Forex Yang Terbesar Tidak Pernah Ditawarkan Sebelum ini ... BONUS TANPA SEBARANG DEPOSIT SEBANYAK $1500 DARI INSTAFOREX !!


Go Back   CariGold Forum > MAKE MONEY DISCUSSION > Forex > Forex Analysis

Forex Analysis Analize forex market trends by using specific method of common analysis. This forum discuss about them in depth.

Recommended Brokers

Forex Chart
Crypto Chart
CG Sponsors



Reply
 
Thread Tools
  #61  
Old 22-01-2019, 11:49 PM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default

Cannabis Stocks’ Prices Grow on the Upbeat U.S. Cannabis Market Outlook
Canada’s cannabis growers’ stocks traded in the U.S. market have been marching vigorously up since 2018 Farm Bill had made hemp, and thus CBD oil, legal across all of the U.S. states.
This news was followed by Canopy Growth’s (CGC) announcement of its having received a license by the state of New York to grow and process hemp and being set to further spread its roots outside Canada, planning to invest somewhere between $100 million and $150 million into its New York-based operations.
Meanwhile, Aurora Cannabis’ CCO said the cannabis grower will unveil a plan to produce hemp-derived CBD for the U.S. market in the next few months.
Contrastingly, Tilray has stood out negatively, as it slid down by about 10% after the IPO lockup had expired. But on the positive side, Tilray will become the preferred supplier for CBD products for Authentic Brands, which might bolster up the cannabis sector’s heavyweight’s stock prices.
Financial scouts predict that the cannabis sector stocks are set to grow in the days to come, given the bright U.S. cannabis market outlook. Specifically, Canopy Growth and Tilray (TLRY) are likely to trade at $44-$45 and $78-$79, respectively. And Aurora Cannabis’, Aphria’s (APHA) and Сronos Group’s (CRON) stock’s respective prices are expected to range $7-$7.5, $7.5-$8, and $16-$17.
Ivan Marchena, Libertex Analyst
Reply With Quote
Paid Advertisement
  #62  
Old 23-01-2019, 01:08 AM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default

Signals Mixed for Europe’s Markets
Financial scouts note that European stock markets now face many incoming cues that are really mixed. The biggest current news on both sides of the spectrum is the Brexit uncertainty and the meaningful progress towards resolving the U.S.-China trade war.
So while the Brexit news make investors feel downbeat with Britain’s withdrawal date very close now and no deal approved yet, the U.S. and China seem to be mending their relationship after the spat. European investors are inspired by the news that the extra-high Chinese imports tariffs might be “reduced and removed”, which is a positive cue for European traders who had previously been worried that the U.S. might introduce new increased on car imports from Europe.
Also, traders in Europe are keeping track of the Davos World Economic Forum news, with some important announcements likely to be made there even though some of the key political figures and leaders like U.S. President Donald Trump and French President Emmanuel Macron are not going to Davos this year.
According to financial scouts, another thing that drives Europe’s markets is oil prices that demonstrate ambiguous dynamics. The medium-term positive driver here was the OPEC+ decision to cut the production that was passed in December 2018. So the decreased oil production eased investors’ concerns over possible oil oversupply.
Ivan Marchena, Libertex Analyst
Reply With Quote
  #63  
Old 25-01-2019, 09:20 PM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default

European Market Sentiment to be Driven by Corporate Reporting Figures, U.S.-China Trade War Resolution Progress

European traders (and investors globally, too) are wary that global economy outlook for the years to come might be gloomy. All of the latest statistics updates flag an impending downturn with leading countries’ economic performances to slow down for the short term at least. This is true for the U.S., Asia, and Europe itself.
Hence, in Europe, all eyes on the U.S.-China trade conflict resolution developments, as the persisting trade spat is a major negative driver for all economies across the globe. But then, there have been some positive cues lately, like U.S. President Donald Trump’s upbeat tweets or comments, suggesting that the trade war may eventually be settled. Mr. Trump is confident that fair trade deal will be reached in one way or another.
Another focus of interest catching the European investors’ attention is the European Bank’s stand on the economic growth outlook both for Europe and globally. Recently, the ECB’s economic growth fears have risen in line with its peers’ economic sentiment pattern.
One more important driver that will shape the European stock market dynamics in the offing is the EU business majors’ quarterly reports that have started to be published. So far, the figures look not too good, making investors feel downbeat.
Ivan Marchena, Libertex Analyst
Reply With Quote
  #64  
Old 29-01-2019, 08:02 PM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default

Cannabis Growers’ Stock to Continue Along the Upward Path on Investors’ Optimism
Canada’s cannabis producers’ stocks have continued to rise, as investors have been anticipating upbeat developments for the sector. Moreover, there is some really good news to propel particular growers’ stocks higher.
Canopy Growth (СGC) has been the sector’s top performer, as its stock had jumped up by more than 80 percent over the first three weeks of January and skyrocketed by 10 percent last Friday on news that major stock analysts had boosted their views on the cannabis company.
The news that really bolstered Canopy Growth stock was the grower’s management’s announcement of the company’s having received a license by the state of New York to grow and process hemp. Now the cannabis producer is set to invest somewhere between $100 million and $150 million into its New York-based “hemp industrial park” where cannabis research and production operations will be combined.
The good news for Tilray (TLRY) was the Canadian cannabis company’s unveiling the deal to buy Natura Naturals Holdings Inc, that is expected to close within the next 30 days.
Given the investors’ optimism, the cannabis stocks are likely to continue climbing to higher levels. The financial scouts forecast that Canopy Growth (СGС) might climb to $50, and Tilray might grow to $77, while Aurora Cannabis Inc (ACB), Aphria Inc. (APHA) and Cronos are predicted to be priced up to $7, $7.5 and $17-$18, respectively.
Ivan Marchena, Libertex Analyst
Reply With Quote
  #65  
Old 01-02-2019, 09:39 PM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default

Cannabis Stocks Grow On Sector’s Strong Earnings Reports

The strong earnings reported by the cannabis sector have provided a powerful growth impetus for the growers’ stocks. A very conspicuous one was Organigram Holdings Inc that reported record high sales growth for the quarter, with the figure topping 400%. The figures as strong as that combined with Organigram management’s planning to double the sales prompted investors to expect that other cannabis companies have a very good upside for growth, too.
Now investors anticipate just as upbeat sales and earnings reports to be published by other cannabis growers. They believe that the sector has started to boom, and many cannabis growers will be able to earn really big money.
Tilray (TLRY) stands out as underperformer, with its stock price declining on the back of the company’s two insiders announcing the sale of their stakes in the business. Tilray CEO Brendan Kennedy sold 149,916 Tilray shares for $11.1 million.
According to financial scouts, the cannabis market will continue to remain upbeat. With the strong financial and production reporting figures likely to be published, Canopy Growth (СGС) and Tilray are likely to grow to appreciable $49-$49.5 and $78-$80, respectively, in the days to come. And Aurora Cannabis Inc (ACB), Aphria Inc. (APHA) and Cronos (CRON) might climb to $7.5-$8, $8-$8.5 and $19-$19.5 in the offing, financial scouts say.

Ivan Marchena, Libertex Analyst
Reply With Quote
  #66  
Old 07-02-2019, 12:41 AM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default

Cannabis producer stocks continue their rally

Increased investor confidence in the future of cannabis is helping shares in Canadian cannabis producers to sustain their rally, This is true of both the medicinal and recreational-use markets. Additionally, the US's legalisation of hemp has opened up this market to a number of major Canadian producers who see significant changes in US legislation on the horizon.
There was even more good news for Cronos Group with industry heavyweight Altria investing $1.8 billion in the company in return for a 45% stake.
Short-term market sentiment will be determined by the quarterly financial reports of Aurora Cannabis (ACB), Cronos Group and Tilray (TLRY), which are to be published within the next few weeks. Investors will be expecting these producers to report sharp sales growth as a result of the recent increase in market outlets. They will also want to hear about their respective 2019 strategies.
For these reasons, we can expect to see increased volatility in this sector and any remotely significant development could trigger a marked jump or abrupt drop in share prices.
Financial scouts are predicting unit share price rises for the major cannabis producers within the following ranges: Canopy Growth (CGC) - $50-50.5, Cronos Group (CRON) $24-25, and Aphria Inc. - $11-12. Meanwhile, they expect shares in Aurora Cannabis to hit the $8.5-9 mark, with Tilray rising as high as $84-85.

Ivan Marchena, Libertex Analyst
Reply With Quote
  #67  
Old 09-02-2019, 03:07 AM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default

No discernible pattern to cannabis producer stock movements but general growth likely
Ambiguous news has meant there is no consistent pattern to cannabis producer share movements. For example, shares in Tilray (TLRY) are rising strongly after reports of a deal with Ohio-based Green Growth Brands that will see the Canadian company supply its US partner with CBD.
Aurora Cannabis Inc's (ACB) share price also increased significantly on news that its partner, Radient Technologies, had been granted a cannabis production license by the Canadian authorities. Following this announcement, the company's shares reached their highest level since the sector-wide boom we saw in November of the previous year.
Meanwhile, Canopy Growth Corp (CGC) is showing slightly lower share price growth, with Aphria Inc (APHA) firmly among the market minnows.
Financial scouts forecast that shares in cannabis producers could continue on their relative up-trend into the near future. Tilray's share price could grow to $80-80.5, while Aurora Cannabis Inc's might reach the $8.5-9 mark. Similarly, we could see Canopy Growth Corp hit $47.5-48, with shares in Aphria Inc and Cronos Group Inc (CRON) rising to $10.5-11 and $22-23 respectively.
Ivan Marchena, Libertex Analyst
Reply With Quote
  #68  
Old 12-02-2019, 12:05 AM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default

Cannabis stocks down on US legalisation doubts

Shares in Canadian cannabis producers are falling amid reports that the New York Department of Health has banned the sale of cannabis in restaurants and bars. Investors now fear that the legalisation of recreational use cannabis in the US is far from certain. Furthermore, the latest figures out of Canada show that the total number of cannabis users did not change significantly following the country's legalisation of the drug in October of last year. The market did however receive some good news in the form of reports suggesting that Thailand is considering decriminalising cannabis. Shares in Canopy Growth Corp (CGC) are demonstrating the best growth in the sector, with investors anticipating the company's entry into the US market. If Canopy Growth succeeds in this ambition, it will most likely "pull up" the shares of some of the smaller players in this sector such as Aphria (APHA), Cronos Group (CRON) and Tilray (TLRY). The latest short-term forecasts from financial scouts predict industry-wide shares growth, with the major players' unit share prices rising to the following levels: Canopy Growth - $46, Tilray - $80, Aurora Canabis Inc (ACB) - $8, Aphria Inc. (APHA) - $10, and Cronos Group - $20.

Ivan Marchena, Libertex Analyst
Reply With Quote
  #69  
Old 14-02-2019, 11:14 PM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default European markets await new developments on Brexit

European markets await new developments on Brexit and US-Chinese trade relations Optimism regarding a resolution to the trade conflict between the US and China could see European stock markets grow. In other news, market insiders have been demonstrating reduced appetite as stocks undergo somewhat of a correction. Investors are choosing to err on the side of caution until they hear the experts' verdict on the current US-China trade talks. The two countries now have just two weeks left in which to reach a decision before the new higher import tariffs come into effect on 1 March. In the meantime, President Donald Trump has already stated publicly that this 1 March deadline for the introduction of new US tariffs on Chinese products could be postponed in the event that a bilateral agreement is close. Such comments are naturally contributing to increased investor optimism across the world. There was some good news for the European markets, too, in the form of rumours claiming Trump is now prepared to sign off on Congress's budget compromise. The budget includes provisions for the construction of an 88-km-long fence along the US's southern border, allocating $1.4 billion to the project as opposed to the $5.7 originally demanded by Trump. Meanwhile, the issue of Brexit remains the main focus of European investors. The United Kingdom's planned departure from the European Union on 29 March is now just six weeks away and, with no final deal in place, investors appear very restless as they react sharply to any Brexit-related news.
Reply With Quote
  #70  
Old 20-02-2019, 09:22 PM
Libertex Libertex is offline
Junior

Libertex's Avatar
 
Trader Rating: (0)
Join Date: Mar 2017
Posts: 87
Thanks (Received): 0
Likes (Received): 0
Active Level
Default

Investors keeping close watch on US-China trade talks and United States' southern border
Investors in the Latin American stock markets are awaiting a decisive solution to the US-China trade conflict with bated breath.
For the time being, however, they remain cautious and are adopting a position of restrained optimism until the result of the talks becomes clear.
High level meetings between the sides are scheduled to take place as early as 21 February and will feature representatives including the Vice Premier of the State Council of the PRC.
Meanwhile, world oil prices are holding steady at their local maximums — which are high now that fears of a supply surplus have been assuaged — and this is benefiting the Latin American market.
The decision by the OPEC nations to reduce their output volumes coupled with the effect of US sanctions on Iran and Venezuela had a similar calming effect.
Elsewhere, financial scouts in Mexico are also carefully monitoring the situation along the US's southern border.
Trump had previously demanded that Congress allocate $5.7 billion dollars for the construction of the President's wall. When this was denied, a number of government departments refused to sign off on the budget for over a month, which resulted in a country-wide institutional shutdown.
In the end, the US Congress passed a budget which provided for just $1.4 billion in funding for a wall along the US-Mexico border. Trump responded by issuing a national emergency order to combat illegal immigration from Mexico and criminality on the US's southern border. This declaration means that the US President will now be able to access up to $8 billion in funds for his wall.
Vadim Kovalenko, Libertex Financial Scout
Reply With Quote
Sponsored Links
Reply

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

AMP
Forum Jump